Work

cfDNA NGS for Identification of Primary and Acquired Resistance in Patients With Lung Cancer and EGFR Mutations

Year: 2023

Type: article

Source: The Journal of Liquid Biopsy

DOI: 10.1016/j.jlb.2023.100047

Authors: A. Peleg, M. Del Re, A. Raphael, X. Wang, A. Berkovich, S. Tsuriel, S. Lichtman, E. Elias, J. Gomez, D. Doroshow, C. Smith, R. Veluswamy, T. Marron, N. Rohs, P. Mack, F. Hirsch, C. Rolfo

Institutions: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, University of Pisa, Tel Aviv Sourasky Medical Center, Mount Sinai Beth Israel

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,080

OpenAlex ID: W4388776550

FWCI:

Cites:

Cited by:

Related to: 10